Radio and PodcastLive Radio & Podcasts
Science & Medicine
Therapeutic HPV Vaccine PepCan Tested for Preventing Head and Neck Cancer Recurrence
Head and neck squamous cell carcinoma (HNSCC) can return even after patients complete surgery, radiation, chemotherapy, or combinations of these treatments. Preventing recurrence therefore remains an important challenge...
Related Episodes
Continue listening to more episodes from Oncotarget.
Epigenetic Silencing of TRAIL-R2 Is Linked to Aggressive Features in Breast Cancer
Oct 6, 2026 - 00:14:04
Gut Microbiome Emerges as a Potential Partner in Precision Cancer Therapy
Sep 28, 2026 - 00:06:09
DHHC3 Helps Melanoma Tumors Evade Antitumor Immunity
Sep 23, 2026 - 00:11:16
Restoring MHC-I Expression Could Strengthen Immune Responses Against CNS Cancers
Sep 9, 2026 - 00:06:42
Oncotarget Supports WIN 2026 Symposium Advancing Precision Oncology
Sep 8, 2026 - 00:02:33